Innate Immunity in Hepatitis C Virus Infection

Area of Science:

• Immunology
• Virology
• Hepatology

Background:

• Hepatitis C virus (HCV) infection involves complex interactions between the virus and the host's innate immune system.
• The balance between immune activation and viral evasion determines spontaneous clearance or chronic infection progression.
• Innate immune responses, particularly interferons, are critical in controlling HCV, while viral strategies aim to circumvent these defenses.

Purpose of the Study:

• To provide a contemporary overview of HCV sensing by host cells and subsequent innate immune activation.
• To elucidate viral mechanisms for evading the host innate immune response.
• To highlight the role of type I and III interferons (IFNs), especially IFN-λ, and interleukin (IL)-1β signaling in HCV infection outcomes and liver pathology.

Main Methods:

• Review of current literature on HCV-innate immunity interactions.
• Analysis of host sensing mechanisms and viral evasion strategies.
• Focus on interferon and IL-1β signaling pathways.

Main Results:

• HCV is sensed by host cells, activating innate immunity, but the virus employs counteracting mechanisms.
• Type I and III IFNs are key antiviral mediators, with IFN-λ genetics significantly impacting infection outcomes.
• IL-1β signaling and its crosstalk with IFN pathways contribute to sustained inflammation and liver disease risk.

Conclusions:

• Understanding HCV-innate immunity interplay is crucial for predicting infection outcomes.
• Host genetic factors, particularly related to IFN-λ, play a significant role in HCV pathogenesis.
• Targeting inflammatory pathways like IL-1β may offer therapeutic strategies for HCV-associated liver disease.